Usual interstitial pneumonia following resolution of cavitated pulmonary masses in a patient with ANCA-associated vasculitis

Int J Rheum Dis. 2018 Apr;21(4):890-894. doi: 10.1111/1756-185X.12430. Epub 2014 Dec 20.

Abstract

A 72-year-old woman with slight pulmonary interstitial reticular markings was initially diagnosed with microscopic polyangiitis (MPA). Two years later, cavitated pulmonary masses appeared, and a biopsy specimen revealed granulomas. Granulomatosis with polyangiitis (GPA) was diagnosed. The masses resolved with treatment. Ten years later, the usual interstitial pneumonia (UIP) pattern appeared on chest computed tomography (CT). The diagnosis of lung toxicity from methotrexate (MTX) or cyclophosphamide (CYC) was precluded by the clinical course. Despite treatment with prednisolone (PSL), the UIP progressed. The change of pulmonary pathology from masses to UIP is rare in patients with GPA.

Keywords: ANCA; cyclophosphamide; interstitial pneumonia; methotrexate; vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cyclophosphamide / adverse effects*
  • Female
  • Glucocorticoids / therapeutic use
  • Granulomatosis with Polyangiitis / diagnosis
  • Granulomatosis with Polyangiitis / drug therapy*
  • Granulomatosis with Polyangiitis / immunology
  • Humans
  • Idiopathic Pulmonary Fibrosis / chemically induced*
  • Idiopathic Pulmonary Fibrosis / diagnosis
  • Idiopathic Pulmonary Fibrosis / drug therapy
  • Idiopathic Pulmonary Fibrosis / immunology
  • Immunosuppressive Agents / adverse effects*
  • Methotrexate / adverse effects*
  • Microscopic Polyangiitis / diagnosis
  • Microscopic Polyangiitis / drug therapy*
  • Microscopic Polyangiitis / immunology
  • Prednisolone / therapeutic use
  • Risk Factors
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Prednisolone
  • Methotrexate